Serum Uric Acid Is Associated with CT-Derived Aortic Valve Calcification in Low-Flow, Low-Gradient Aortic Stenosis

Anıl Avcı1, Emre Kipritçi1, İbrahim Veyisoğlu1

  • 1Department of Cardiology, Koşuyolu Cardiovascular Training and Research Hospital, Istanbul 34865, Türkiye.

Insights

Elevated serum uric acid levels correlate with aortic valve calcification in patients with low-flow, low-gradient aortic stenosis. Higher uric acid may indicate true severe disease, aiding in assessment.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Imaging

Background:

  • Low-flow, low-gradient aortic stenosis (LF-LG AS) with reduced ejection fraction presents diagnostic challenges.
  • Aortic valve calcification (AVC) is linked to fibro-calcific remodeling and oxidative stress.
  • Serum uric acid (SUA), a marker of oxidative stress, may relate to AVC severity.

Purpose of the Study:

  • To investigate the association between serum uric acid levels and aortic valve calcification.
  • To explore SUA as a potential marker for differentiating true severe LF-LG AS from pseudo-severe cases.

Main Methods:

  • Retrospective analysis of 85 patients with LF-LG AS.
  • Quantification of AVC using computed tomography (CT) Agatston method.
  • Classification of patients into true severe and pseudo-severe AS based on sex-specific calcium thresholds.

Main Results:

  • Higher AVC burden was significantly associated with elevated SUA levels (p < 0.001).
  • SUA showed a modest correlation with AVC score (ρ = 0.339, p = 0.002).
  • SUA remained independently associated with CT-defined true severe LF-LG AS in multivariable analysis, with a threshold of 5.45 mg/dL indicating higher likelihood.

Conclusions:

  • Serum uric acid is linked to CT-derived aortic valve calcification.
  • SUA may offer insights into the fibro-calcific remodeling process in LF-LG AS.
  • SUA could serve as a non-invasive biomarker for assessing LF-LG AS severity.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...